Use of an angiotensin converting enzyme inhibitor or angiotensin receptor blocker for the prevention of diabetes mellitus: a meta-analysis.

被引：0
|
作者：
Kardas, M
Gillespie, EL
White, CM
Coleman, CI
机构：
[1] Univ Connecticut, Storrs, CT USA
[2] Univ Connecticut, Hartford Hosp, Hartford, CT 06112 USA
来源：
PHARMACOTHERAPY | 2005年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
052
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [41] Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker
    Tanemoto, M
    Abe, T
    Obara, N
    Abe, M
    Satoh, F
    Ito, S
    [J]. HYPERTENSION RESEARCH, 2003, 26 (10) : 863 - 868
  • [42] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    [J]. CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [43] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [44] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [45] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    [J]. CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [46] Diabetes Mellitus and Angiotensin Converting Enzyme Inhibitors
    Ahmed, Almoutaz Alkhier
    [J]. WORLD FAMILY MEDICINE, 2007, 5 (01): : 31 - 35
  • [47] Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Acute Myocardial Infarction Patients: A Meta-Analysis of Randomized Controlled Trials
    Ananta, Muammar Emir
    Ivan, Ignatius
    Wijaya, Alya Darin
    Albab, Chabib Fachry
    Danny, Siska
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (16) : S23 - S24
  • [48] USE OF ANGIOTENSIN RECEPTOR BLOCKERS AFTER ANGIOEDEMA WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR
    Haymore, Bret R.
    DeZee, Kent J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (01) : 83 - 84
  • [49] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
    Healey, JS
    Baranchuk, A
    Crystal, E
    Morillo, CA
    Garfinkle, M
    Yusuf, S
    Connolly, SJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1832 - 1839
  • [50] Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of Randomized controlled trials
    Lakhdar, Rachid
    Al-Mallah, Mouaz H.
    Lanfear, David E.
    [J]. JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) : 181 - 188
12345